Cargando…

Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics

Detalles Bibliográficos
Autores principales:	Sintobin, Ina, Vennera, Maria del Carmen, Mullol, Joaquim, Bachert, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493502/ http://dx.doi.org/10.1186/2045-7022-5-S4-O11

Ejemplares similares

Uncontrolled chronic rhinosinusitis with and without polyps is predicted by T cell subtype
por: Kosak, Tanja Soklic, et al.
Publicado: (2015)

The dynamics of the manifestations of atopic dermatitis in severe persistent uncontrolled asthma children with omalizumab therapy
por: Vishneva, Elena, et al.
Publicado: (2015)

Omalizumab in the treatment of severe allergic (IgE-mediated) asthma: an update on recent developments
por: Humbert, Marc, et al.
Publicado: (2013)

Nasal polyps, aspirin sensitivity, and late onset asthma are crucial to identify severe asthma. clinicaltrials.gov id : nct01513837
por: Castillo, José A, et al.
Publicado: (2015)

Toll-like receptor expression in severe asthma with chronic rhinosinusitis
por: Malmhäll, Carina, et al.
Publicado: (2013)

Asthmatic children that are uncontrolled despite inhaled corticosteroids have a distinct breathprint (the pacman2 study)
por: Vijverberg, Susanne, et al.
Publicado: (2015)

Metabolomic applied to omalizumab effect in severe asthmatics – a preliminary result
por: Loureiro, Cláudia Chaves, et al.
Publicado: (2013)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019)

Genome wide gene expression analysis of nasal mucosa from patients with chronic rhinosinusitis and nasal polyposis stimulated with staphylococcal enterotoxin B
por: Perez Novo, Claudina, et al.
Publicado: (2015)

Matrix metalloproteinases, tissue inhibitor of metalloproteinase and transforming growth factor A1 in the remodeling of chronic rhinosinusitis in North China
por: Wang, XiangDong, et al.
Publicado: (2013)

Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023)

Omalizumab Restores Response to Corticosteroids in Patients with Eosinophilic Chronic Rhinosinusitis and Severe Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2021)

Omalizumab in patients with severe uncontrolled asthma: well-defined eligibility criteria to promote asthma control
por: de Carvalho-Pinto, Regina Maria, et al.
Publicado: (2017)

Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials
por: Mullol, Joaquim, et al.
Publicado: (2021)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2021)

A new intranasal therapy (MP29-02*) is more effective than current firstline therapy regardless of season, symptom or severity.
por: Bachert, Claus, et al.
Publicado: (2015)

Omalizumab for severe allergic asthma: a life changing drug?
por: Mesonjesi, Eris, et al.
Publicado: (2015)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018)

Follow-up of asthma control and quality of life after discontinuation of omalizumab in severe asthmatic patients
por: Nayci, Sibel, et al.
Publicado: (2015)

Chemoattractant levels in nasal secretions as indicators of clinical severity in chronic polypous rhinosinusitis
por: Peric, Aleksandar, et al.
Publicado: (2013)

A new allergic rhinitis therapy (MP29-02*) provides effective and rapid symptom relief for patients who suffer most from the bothersome symptoms of nasal congestion or ocular itch
por: Fokkens, Wytske, et al.
Publicado: (2015)

Leukocyte infiltration patterns and structural changes in severe asthmatics with variable degree of clinical control
por: Anders, Bergqvist, et al.
Publicado: (2015)

Sputum “IL-5, IL-17A, IL-25-high” pattern is associated with uncontrolled asthma and worse lung function
por: Seys, Sven, et al.
Publicado: (2013)

Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic
por: Kirchnerová, Olga Růžičková, et al.
Publicado: (2018)

Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2015)

Comparison of different medical treatment options for CRSwNP: doxycycline, methylprednisolone, mepolizumab and omalizumab
por: De Schryver, Els, et al.
Publicado: (2015)

P87 - A national multicenter registration of treatment with omalizumab in Danish asthmatic children
por: Spangenberg, Katrine B, et al.
Publicado: (2014)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

A new therapy (MP29-02*) effectively controls nasal symptoms of seasonal allergic rhinitis irrespective of severity
por: Scadding, Glenis, et al.
Publicado: (2013)

Symptoms of chronic rhinosinusitis with and without nasal polyps
por: Dietz de Loos, Dirk, et al.
Publicado: (2013)

A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment
por: Davison, John, et al.
Publicado: (2021)

Impact of Omalizumab in Patients with Severe Uncontrolled Asthma and Possible Predictive Biomarkers of Response: A Real-Life Study
por: Rojo-Tolosa, Susana, et al.
Publicado: (2023)

An epidemiological perspective on severe asthma
por: Mincheva, Roxana, et al.
Publicado: (2015)

Analysis of the IgE- and IgG-reactivity profiles of asthmatic and non-asthmatic HDM-allergic patients using the ISAC microarray system
por: Resch, Yvonne, et al.
Publicado: (2014)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Allergic fungal rhinosinusitis (AFRS) - more than a fungal disease?
por: Dutre, Tineke, et al.
Publicado: (2013)

Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression
por: Vogt, Florian, et al.
Publicado: (2021)

Crowdsourcing to explore views about asthma severity among asthma experts
por: Lötvall, Jan, et al.
Publicado: (2013)

Effective omalizumab treatment influenced eosinophil function in severe allergic asthmatics
por: Yan, Huacheng, et al.
Publicado: (2023)

The ‘GA²LEN Sinusitis Cohort’: an introduction
por: Vandeplas, Griet, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ig8jfk70m2smjppliam4bq250n